Lewis Levy Sells 675 Shares of Teladoc Health Inc (NYSE:TDOC) Stock

Teladoc Health Inc (NYSE:TDOC) insider Lewis Levy sold 675 shares of the stock in a transaction that occurred on Monday, June 17th. The shares were sold at an average price of $60.00, for a total transaction of $40,500.00. Following the completion of the transaction, the insider now owns 4,805 shares of the company’s stock, valued at $288,300. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Lewis Levy also recently made the following trade(s):

  • On Wednesday, July 10th, Lewis Levy sold 2,700 shares of Teladoc Health stock. The shares were sold at an average price of $70.00, for a total transaction of $189,000.00.
  • On Monday, July 1st, Lewis Levy sold 1,350 shares of Teladoc Health stock. The shares were sold at an average price of $67.95, for a total transaction of $91,732.50.
  • On Monday, June 3rd, Lewis Levy sold 675 shares of Teladoc Health stock. The shares were sold at an average price of $58.00, for a total transaction of $39,150.00.
  • On Wednesday, May 1st, Lewis Levy sold 2,025 shares of Teladoc Health stock. The shares were sold at an average price of $60.00, for a total transaction of $121,500.00.
  • On Thursday, April 11th, Lewis Levy sold 675 shares of Teladoc Health stock. The shares were sold at an average price of $56.80, for a total transaction of $38,340.00.

Shares of NYSE:TDOC traded down $0.48 during midday trading on Friday, reaching $70.62. 921,349 shares of the company’s stock were exchanged, compared to its average volume of 973,821. The business has a 50 day moving average price of $61.87. The stock has a market cap of $5.06 billion, a price-to-earnings ratio of -49.04 and a beta of 1.30. Teladoc Health Inc has a 12 month low of $42.08 and a 12 month high of $89.05. The company has a debt-to-equity ratio of 0.42, a current ratio of 7.54 and a quick ratio of 7.54.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Tuesday, April 30th. The health services provider reported ($0.43) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.44) by $0.01. Teladoc Health had a negative net margin of 22.63% and a negative return on equity of 10.86%. The firm had revenue of $128.57 million during the quarter, compared to the consensus estimate of $127.99 million. During the same period last year, the firm posted ($0.39) EPS. The firm’s quarterly revenue was up 43.4% on a year-over-year basis. As a group, equities research analysts expect that Teladoc Health Inc will post -1.53 EPS for the current year.

Several equities research analysts recently commented on TDOC shares. Zacks Investment Research downgraded shares of Inflarx from a “buy” rating to a “hold” rating in a research report on Friday, May 3rd. Guggenheim started coverage on shares of Patterson Companies in a research report on Wednesday, April 17th. They issued a “neutral” rating and a $23.00 target price for the company. Cantor Fitzgerald restated a “buy” rating and set a $143.00 price target on shares of Eli Lilly And Co in a research note on Tuesday, April 30th. Craig Hallum increased their price target on shares of 1-800-Flowers.Com from $26.00 to $20.00 and gave the stock a “buy” rating in a research note on Wednesday, May 1st. Finally, Jefferies Financial Group restated a “buy” rating on shares of Extended Stay America in a research note on Tuesday, July 2nd. Three investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $82.68.

Institutional investors and hedge funds have recently bought and sold shares of the business. Enlightenment Research LLC acquired a new stake in shares of Teladoc Health during the 4th quarter worth approximately $25,000. Nikko Asset Management Americas Inc. acquired a new stake in shares of Teladoc Health during the 4th quarter worth approximately $25,000. CENTRAL TRUST Co grew its position in shares of Teladoc Health by 82.6% during the 2nd quarter. CENTRAL TRUST Co now owns 378 shares of the health services provider’s stock worth $27,000 after buying an additional 171 shares during the period. Tompkins Financial Corp acquired a new position in Teladoc Health during the first quarter valued at approximately $31,000. Finally, Ffcm LLC acquired a new position in Teladoc Health during the fourth quarter valued at approximately $32,000.

Teladoc Health Company Profile

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Read More: How to interpret a stock’s beta number

Insider Buying and Selling by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.